高级检索
当前位置: 首页 > 详情页

The water extract of Anoectochilus formosanus protects mice from concanavalin A-induced hepatitis

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]China Three Gorges Univ, Coll Clin Med Sci 1, Yichang, Peoples R China [2]Yichang Cent Peoples Hosp, 183 Yiling Ave, Yichang 443003, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Hubei Key Lab Nat Med Chem & Resource Evaluat, Wuhan, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China
出处:
ISSN:

关键词: Anoectochilus formosanus concanavalin A hepatitis NF kappa B

摘要:
Anoectochilus formosanus, a famous traditional Chinese medicine, has been used as a source of folk medicine alternative liver injury therapy. Here, we evaluate the hepatoprotective potential of water extract of Anoectochilus formosanus Hayata (WEAF). The cultured splenocytes and concanavalin A (ConA)-induced hepatitis model in mice were established to investigate the immunoregulation and hepatoprotection of WEAF. In vitro, WEAF inhibited the production of TNF-alpha, IFN-gamma and IL-4 in ConA-stimulated splenocytes. In vivo, mice pretreated with WEAF followed by ConA challenge showed reduction of liver damage. Pre-treatment with WEAF significantly decreased transaminase levels and hepatocyte apoptosis in ConA-injected mice. WEAF possessed potent anti-inflammatory and hepatoprotective activity. WEAF attenuated hepatic inflammation via up-regulation of IL-10 and down-regulation of TNF-alpha, IFN-gamma, IL-4 and IL-6. Furthermore, WEAF ameliorated the intrahepatic infiltration of CD4(+)T and CD8(+)T cells, decreased the iNOS expression, as well as inhibited nuclear factor kappa B (NF kappa B) activation and Toll-like receptor 4 (TLR4) expression. Our findings provided evidences that WEAF had great potential to develop new immunomodulatory agent to treat immune-mediated hepatitis.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
JCR分区:
出版当年[2016]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]China Three Gorges Univ, Coll Clin Med Sci 1, Yichang, Peoples R China [2]Yichang Cent Peoples Hosp, 183 Yiling Ave, Yichang 443003, Peoples R China
通讯作者:
通讯机构: [1]China Three Gorges Univ, Coll Clin Med Sci 1, Yichang, Peoples R China [2]Yichang Cent Peoples Hosp, 183 Yiling Ave, Yichang 443003, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Hubei Key Lab Nat Med Chem & Resource Evaluat, Wuhan, Hubei, Peoples R China [*1]Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)